⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 30, 2024World Journal of TransplantationOpen Access

Impact of hepatitis B immunoglobulin mode of administration on treatment experiences of patients after liver transplantation: Results from an online survey

Giorgia Rizza Kyriaki Glynou Masha Eletskaya

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Hepatitis B immunoglobulin (HBIG) in combination with a potent nucleos(t)ide analog is considered the standard of care for prophylaxis against hepatitis B virus (HBV) reinfection after liver transplantation for HBV-associated disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rizza et al. (2024) studied this question.

synapsesocial.com/papers/68e5e808b6db64358757ceb8 https://doi.org/10.5500/wjt.v14.i3.90949

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Management of Hepatitis B in Liver Transplantation PatientsOriginal Research · 2004 · 53 citations
2The UK experience with hepatitis B immunoglobulin use following liver transplantation: wide variation in practice despite evidence supporting cost-effective HBIG-free prophylaxisCohort Study · 2026 · 2 citations
3Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantationCohort Study · 1999 · 147 citations
4Hepatitis B Immunoglobulins Withdrawal in Hepatitis B Virus Mono‐Infected Liver Transplant Recipients: An Italian Multicentre Prospective Study2025 · 1 citations
5Long‐Term Outcomes of Patients Who Receive a Liver Transplant for Hepatitis B With Limited Use of Hepatitis B Immunoglobulin2025
6Long‐Term Outcomes of Patients Who Receive a Liver Transplant for Hepatitis B With Limited Use of Hepatitis B Immunoglobulin2025
7Hepatitis D virus reactivation in liver-transplanted patients receiving hepatitis B immunoglobulin2024 · 3 citations
8Efficacy of Newer Nucleos(t)ide Analogs After Hepatitis B Immunoglobulin Discontinuation Against Hepatitis B and D Recurrence in Liver Transplant Recipients2024 · 5 citations
9Exploratory circulating miRNA profile associated with cardiac allograft antibody-mediated rejection: A pilot single-center studyWorld Journal of Transplantation · 2026
10Machine perfusion distribution across clinical phenotypes in kidney transplantation: A national cohort study using unsupervised clusteringWorld Journal of Transplantation · 2026

More from World Journal of Transplantation

More from Azienda Ospedaliero Universitaria San Giovanni Battista

More from Biotest (Germany)

More from Insight Healthcare